Quince Therapeutics, Inc. (QNCX)

1.29 -0.08 (-5.84%) USD  |  NASDAQ  |  Apr 20, 09:45
More

Quince Therapeutics SG&A Expense (Quarterly) : 3.635M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for QNCX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. 33.66M
Ocular Therapeutix, Inc. 30.62M
Gossamer Bio, Inc. 10.90M
Ernexa Therapeutics, Inc. 1.418M
Acurx Pharmaceuticals, Inc. 1.335M